Dorsal-to-ventral imbalance in the superior longitudinal fasciculus mediates methylphenidate's effect on beta oscillations in ADHD
- PMID: 35165906
- PMCID: PMC9287074
- DOI: 10.1111/psyp.14008
Dorsal-to-ventral imbalance in the superior longitudinal fasciculus mediates methylphenidate's effect on beta oscillations in ADHD
Abstract
While pharmacological treatment with methylphenidate (MPH) is a first line intervention for ADHD, its mechanisms of action have yet to be elucidated. We here seek to identify the white matter tracts that mediate MPH's effect on beta oscillations. We implemented a double-blind placebo-controlled crossover design, where boys diagnosed with ADHD underwent behavioral and MEG measurements during a spatial attention task while on and off MPH. The results were compared with an age/IQ-matched control group. Estimates of white matter tracts were obtained using diffusion tensor imaging (DTI). Via a stepwise model selection strategy, we identified the fiber tracts (regressors) significantly predicting values of the dependent variables of interest (i.e., oscillatory power, behavioral performance, and clinical symptoms): the anterior thalamic radiation (ATR), the superior longitudinal fasciculus ("parietal endings") (SLFp), and superior longitudinal fasciculus ("temporal endings") (SLFt). ADHD symptoms severity was associated with lower fractional anisotropy (FA) within the ATR. In addition, individuals with relatively higher FA in SLFp compared to SLFt, led to stronger behavioral effects of MPH in the form of faster and more accurate responses. Furthermore, the same parietotemporal FA gradient explained the effects of MPH on beta modulation: subjects with ADHD exhibiting higher FA in SLFp compared to SLFt also displayed greater effects of MPH on beta power during response preparation. Our data suggest that the behavioral deficits and aberrant oscillatory modulations observed in ADHD depend on a possibly detrimental structural connectivity imbalance within the SLF, caused by a diffusivity gradient in favor of parietal rather than temporal, fiber tracts.
Keywords: ADHD; meg; methylphenidate; oscillations.
© 2022 The Authors. Psychophysiology published by Wiley Periodicals LLC on behalf of Society for Psychophysiological Research.
Figures










Similar articles
-
Prediction of methylphenidate treatment response for ADHD using conventional and radiomics T1 and DTI features: Secondary analysis of a randomized clinical trial.Neuroimage Clin. 2025;45:103707. doi: 10.1016/j.nicl.2024.103707. Epub 2024 Nov 21. Neuroimage Clin. 2025. PMID: 39591718 Free PMC article. Clinical Trial.
-
White Matter by Diffusion MRI Following Methylphenidate Treatment: A Randomized Control Trial in Males with Attention-Deficit/Hyperactivity Disorder.Radiology. 2019 Oct;293(1):186-192. doi: 10.1148/radiol.2019182528. Epub 2019 Aug 13. Radiology. 2019. PMID: 31407970 Clinical Trial.
-
Sex differences in microstructural alterations in the corpus callosum tracts in drug-naïve children with ADHD.Brain Imaging Behav. 2022 Aug;16(4):1592-1604. doi: 10.1007/s11682-021-00556-y. Epub 2022 Jan 31. Brain Imaging Behav. 2022. PMID: 35102486
-
White matter endophenotype candidates for ADHD: a diffusion imaging tractography study with sibling design.Psychol Med. 2020 May;50(7):1203-1213. doi: 10.1017/S0033291719001120. Epub 2019 May 22. Psychol Med. 2020. PMID: 31115278 Clinical Trial.
-
Research Review: Diffusion tensor imaging studies of attention-deficit/hyperactivity disorder: meta-analyses and reflections on head motion.J Child Psychol Psychiatry. 2018 Mar;59(3):193-202. doi: 10.1111/jcpp.12778. Epub 2017 Jul 3. J Child Psychol Psychiatry. 2018. PMID: 28671333
Cited by
-
Attention-deficit/hyperactivity disorder and white matter microstructure: the importance of dimensional analyses and sex differences.JCPP Adv. 2022 Dec;2(4):e12109. doi: 10.1002/jcv2.12109. Epub 2022 Nov 15. JCPP Adv. 2022. PMID: 36817187 Free PMC article.
-
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3. Cochrane Database Syst Rev. 2023. PMID: 36971690 Free PMC article.
-
Alpha/beta-gamma decoupling in methylphenidate medicated ADHD patients.Front Neurosci. 2023 Sep 29;17:1267901. doi: 10.3389/fnins.2023.1267901. eCollection 2023. Front Neurosci. 2023. PMID: 37841679 Free PMC article.
-
Prediction of methylphenidate treatment response for ADHD using conventional and radiomics T1 and DTI features: Secondary analysis of a randomized clinical trial.Neuroimage Clin. 2025;45:103707. doi: 10.1016/j.nicl.2024.103707. Epub 2024 Nov 21. Neuroimage Clin. 2025. PMID: 39591718 Free PMC article. Clinical Trial.
-
Poor response to methylphenidate is associated with a smaller dorsal attentive network in adult Attention-Deficit/Hyperactivity Disorder (ADHD).Transl Psychiatry. 2023 Sep 30;13(1):303. doi: 10.1038/s41398-023-02598-w. Transl Psychiatry. 2023. PMID: 37777529 Free PMC article.
References
-
- American Psychiatric Association . (2013). Diagnostic and statistical manual of mental disorders (5th ed.) (A. P. Association & A. P. A. D.‐5 T. Force [eds.]). American Psychiatric Association. 10.1176/appi.books.9780890425596 - DOI
-
- Arns, M. , Vollebregt, M. A. , Palmer, D. , Spooner, C. , Gordon, E. , Kohn, M. , Clarke, S. , Elliott, G. R. , & Buitelaar, J. K. (2018). Electroencephalographic biomarkers as predictors of methylphenidate response in attention‐deficit/hyperactivity disorder. European Neuropsychopharmacology, 28(8), 881–891. 10.1016/j.euroneuro.2018.06.002 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous